Wearables, Telehealth, Testing Platforms & Employers
Three markets.
Three gaps.
One missing piece.
Wearables built the most sophisticated biometric data set in history. Telehealth built new lines to clinical expertise. Testing platforms revealed the science of biomarkers. Each one hit a wall.
Data without a plan. Expertise that doesn't scale. Science without practical application.
LERA is the clinical action layer.
Built on 22 years of clinical experience and 20,000 women — turning symptoms, biomarkers, and user data into personalized whole-body guidance. Now you can plug in.
The market gap
Every platform in women's health is facing a build-versus-buy decision around the action layer. We've already built it.
Wearables
Built the most sophisticated biometric data set in history. But data without action is just a dashboard.
→ Ready for an action layer.
Telehealth
Built real clinical expertise. But a model dependent on 1:1 visits doesn't scale.
→ Ready for a scale layer.
Testing platforms
Made biomarkers visible in ways not possible five years ago. But visibility without a plan leaves women stuck.
→ Ready for a plan layer.
The problem at scale
Fragmentation isn't just inefficient — it's expensive. For women, employers, and the platforms trying to serve them.
17%
average utilization across fragmented women's health offerings
SHRM 2025
$150B
in lost productivity tied to women's unaddressed health conditions
McKinsey 2024
87%
of employers say measuring ROI on health benefits is a top challenge
McKinsey 2025
LERA works
The subjective and objective lined up.
Every time.
In digital health, that almost never happens. Women reported feeling better — and their biomarkers agreed. That's not engagement data. That's a clinical outcome.
94%
Member retention
Paying members over 6 months. Industry median: 48%.
72
Net Promoter Score
Healthcare average: 38. Score of 70+ = world class.
Symptom reduction
% of women reporting improvement
78%
Stress, resilience & sleep
75%
Hormones, cycle & mood
78%
Gut, digestion & comfort
78%
Metabolic, diet & movement
Biomarker improvement
% of women with measurable change
71%
Inflammation markers reduced
100%
Nutrient deficiencies corrected
89%
Members lost weight
74%
Food sensitivities resolved
Source: White Paper Report, LERA Health's Lifestyle Medicine Intervention Validated in Cohort Study
How we work together
Three paths to partnership. One destination — LERA embedded inside the women's health ecosystem.
Your data deserves better outcomes.
LERA turns your platform's signals into clinical context, personalized guidance, and real health changes. That's what keeps members engaged — and subscribed — long term.
Solve churn at the root. Members leave when data doesn't translate to action. LERA closes the loop between insight and outcome — eliminating the "so what?" that drives drop-off.
Increase LTV. Longitudinal, whole-body care creates lasting engagement. Members who see results — in their symptoms and their biomarkers — stay.
Add clinical credibility. LERA's biomarker + behavior + coaching layer adds clinical weight to your platform — differentiating you in a crowded market.
White-label ready. LERA is built, clinically and technically, to integrate inside wearable, telehealth, and testing platforms.
“For decades, women have been handed pieces of the puzzle — a lab result, a diagnosis, a one-size-fits-all recommendation — but never the full picture. Never a system that sees it all together and actually tells them what to do. That's the void LERA fills.”
— Jennifer Voss, Co-Founder & CEO, LERA Health
Ready to plug in?
We're selectively building partnerships with platforms and employers who share our conviction that women's health is a systems problem — and that solving it changes everything.
If that's you, let's talk.